ALIM Alimera Sciences Inc

Price (delayed)

$9.99

Market cap

$69.09M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.43

Enterprise value

$105.58M

Highlights
Alimera Sciences's net income has decreased by 46% QoQ but it has increased by 12% YoY
The EPS has contracted by 38% from the previous quarter but it has grown by 22% YoY
The equity has dropped by 121% year-on-year and by 50% since the previous quarter
Alimera Sciences's quick ratio has decreased by 31% YoY and by 7% QoQ

Key stats

What are the main financial stats of ALIM
Market
Shares outstanding
6.92M
Market cap
$69.09M
Enterprise value
$105.58M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
1.21
EV/EBIT
N/A
EV/EBITDA
552.78
EV/Sales
2.22
Earnings
Revenue
$47.5M
EBIT
-$2.47M
EBITDA
$191,000
Free cash flow
-$5.92M
Per share
EPS
-$1.43
Free cash flow per share
-$1.03
Book value per share
-$2.08
Revenue per share
$8.25
TBVPS
$5.77
Balance sheet
Total assets
$45.59M
Total liabilities
$57.55M
Debt
$44.8M
Equity
-$11.96M
Working capital
$19.12M
Liquidity
Debt to equity
-3.75
Current ratio
2.71
Quick ratio
2.14
Net debt/EBITDA
191.07
Margins
EBITDA margin
0.4%
Gross margin
86.2%
Net margin
-16.4%
Operating margin
-6.6%
Efficiency
Return on assets
-16%
Return on equity
N/A
Return on invested capital
-4.3%
Return on capital employed
-7.2%
Return on sales
-5.2%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ALIM stock price

How has the Alimera Sciences stock price performed over time
Intraday
-3.01%
1 week
-3.29%
1 month
16.57%
1 year
92.86%
YTD
136.73%
QTD
3.85%

Financial performance

How have Alimera Sciences's revenue and profit performed over time
Revenue
$47.5M
Gross profit
$40.92M
Operating income
-$3.15M
Net income
-$7.79M
Gross margin
86.2%
Net margin
-16.4%
ALIM's net margin has dropped by 56% since the previous quarter and by 2.5% year-on-year
Alimera Sciences's net income has decreased by 46% QoQ but it has increased by 12% YoY
Alimera Sciences's gross profit has decreased by 16% YoY and by 7% from the previous quarter
The revenue has declined by 15% year-on-year and by 7% since the previous quarter

Growth

What is Alimera Sciences's growth rate over time

Valuation

What is Alimera Sciences stock price valuation
P/E
N/A
P/B
N/A
P/S
1.21
EV/EBIT
N/A
EV/EBITDA
552.78
EV/Sales
2.22
The EPS has contracted by 38% from the previous quarter but it has grown by 22% YoY
The equity has dropped by 121% year-on-year and by 50% since the previous quarter
The stock's P/S is 73% more than its last 4 quarters average of 0.7 but 19% less than its 5-year quarterly average of 1.5
The revenue has declined by 15% year-on-year and by 7% since the previous quarter

Efficiency

How efficient is Alimera Sciences business performance
Alimera Sciences's return on assets has decreased by 48% QoQ but it has increased by 12% YoY
ALIM's ROIC is up by 41% YoY
The ROS has grown by 24% YoY

Dividends

What is ALIM's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ALIM.

Financial health

How did Alimera Sciences financials performed over time
Alimera Sciences's total assets is 21% less than its total liabilities
Alimera Sciences's quick ratio has decreased by 31% YoY and by 7% QoQ
The current ratio has declined by 23% year-on-year and by 4.2% since the previous quarter
The equity has dropped by 121% year-on-year and by 50% since the previous quarter
The debt to equity has soared by 51% YoY and by 33% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.